ETS Surgery for Blushing: Costs, Risks, and What Surgeons Don't Lead With

Endoscopic Thoracic Sympathectomy — ETS — is the most extreme intervention available for facial blushing. People who pursue it have typically spent years trying everything else: therapy, medication, breathing exercises, avoidance strategies. When those fail and the blushing continues to destroy careers and relationships, surgery starts to look like the only remaining option.

It is important to understand exactly what ETS does before reaching that conclusion. The procedure has a high success rate for eliminating the target symptom. It also has a near-universal rate of a different, often more disruptive symptom in its place.

Medical disclaimer: This article draws on published clinical and medical literature for informational context. It does not constitute medical advice. Consult a qualified surgeon and your primary care physician before pursuing any surgical intervention.

What ETS Surgery Does

The sympathetic nervous system includes a nerve chain running parallel to the spine inside the chest cavity. Branches of this chain carry signals that cause facial vasodilation — the mechanism of blushing. ETS involves inserting a camera into the chest cavity, partially collapsing one lung to create access, and severing, clamping, or destroying a portion of the sympathetic nerve trunk, typically at the T2 or T3 ganglion level.

The result is a permanent interruption of the nerve signals that cause facial blushing. The procedure typically takes one to two hours under general anesthesia and is performed as day surgery or with one overnight stay.

Success rates for eliminating facial blushing are high. Studies report initial satisfaction rates of 73% to 89%, with some surgical centers claiming 90% to 95% success rates for the target symptom. The blushing stops or reduces dramatically for the large majority of patients.

The Problem: Compensatory Sweating

The sympathetic nervous system uses the same nerve pathways for temperature regulation across the entire body. When ETS permanently disables the upper section of that pathway, the body does not simply reduce its sweating capacity — it redistributes. The lower body compensates by sweating dramatically more from the areas still innervated: the trunk, abdomen, back, and thighs.

This is called compensatory sweating (CS), and clinical data puts its incidence at up to 98% to 99% of ETS patients. Most patients experience some degree of it. A significant proportion — estimates vary from 30% to over 50% depending on the study — describe it as severe or very severe: soaking through clothing from the waist down during mild physical activity, profuse sweating in warm environments, and episodes during ordinary social situations.

For many patients, the compensatory sweating becomes more socially and occupationally disruptive than the blushing it replaced. Procedure regret rates, measured at roughly 7% to 8% initially, climb to over 13% as time progresses and the full impact of compensatory sweating becomes apparent. The nerve transaction is largely irreversible — reversal surgery exists but has limited and unpredictable results.

Other documented complications include:

• Horner's syndrome: drooping of one eyelid, unequal pupil size, and facial anhidrosis (inability to sweat on one side of the face), resulting from inadvertent damage to adjacent nerve structures
• Heat intolerance: because the upper body's cooling mechanism is disabled, patients can struggle to regulate body temperature in warm environments
• Gustatory sweating: sweating triggered by eating or smelling food
• Bradycardia: slowed heart rate, due to sympathetic innervation of the heart

The severity of these outcomes varies. Some patients experience minimal compensatory sweating and consider the trade worthwhile. Others deeply regret the procedure. There is currently no reliable way to predict which group a given patient will fall into.

ETS Surgery Cost

In the United States, ETS costs $5,000 to $20,000, not including anesthesia fees, facility costs, and post-operative care. Most US health insurers classify the procedure as elective and do not cover it. Some insurance plans will cover it when it is performed for hyperhidrosis (excessive sweating) rather than blushing specifically, which affects how surgeons code the indication.

In the United Kingdom, ETS is available privately and occasionally through the NHS for severe hyperhidrosis cases. Private costs in the UK typically range from £3,000 to £8,000. NHS referrals require documented failure of non-surgical treatments and approval through a specialist pathway.

In Australia, the procedure is performed privately with costs typically in the AUD $5,000 to $12,000 range. Medicare does not cover ETS for blushing. Some private health funds cover it under hospital benefits for approved surgical procedures.

In Canada, coverage varies by province. In provinces where ETS is covered, it is typically only for severe, documented hyperhidrosis with evidence of failed conservative treatments.

The phrase "ets surgery near me" reflects a practical search — finding an appropriate surgeon. Thoracic surgeons with specific experience in ETS are the relevant specialists. Not all thoracic surgeons perform it; in the UK, NHS consultant thoracic surgeons at specialist centers handle the bulk of cases.

Sweden's Ban and the International Context

ETS was developed in Sweden. Sweden subsequently banned the procedure after accumulating data on the prevalence and severity of compensatory sweating outcomes. This is a significant fact that often does not appear prominently in surgical marketing materials. The country that developed ETS concluded that the risk-benefit profile was unacceptable.

Other countries have not enacted formal bans but have seen medical associations issue warnings. US and UK thoracic surgery guidelines classify ETS as a procedure of last resort, requiring extensive documentation of failed conservative treatments and psychological evaluation confirming the patient understands the risks and has realistic expectations.

Who Should and Should Not Consider ETS

The patients for whom ETS outcomes tend to be most favorable are those with focal, severe hyperhidrosis (excessive sweating in specific regions) rather than pure erythrophobia (fear of blushing). The research on ETS specifically for blushing — as distinct from sweating — shows more mixed outcomes than the headline success rates suggest, partly because blushing carries a significant psychological component that surgery does not address.

Most surgeons with experience in ETS will not proceed without evidence that the patient has:

• Had a thorough evaluation by a psychiatrist or psychologist
• Attempted and documented failure of CBT or structured psychological treatment
• Tried pharmacological interventions (beta blockers, SSRIs)
• Understood the compensatory sweating risk clearly and in detail

If you are researching ETS because behavioral and pharmacological approaches have genuinely failed and you are severely impaired by blushing, the conversation with a thoracic surgeon is worth having. But it should happen after, not before, a serious attempt at evidence-based psychological treatment.

Cognitive Behavioral Therapy, Paradoxical Intention, and Task Concentration Training have strong clinical evidence for erythrophobia specifically. They carry no surgical risk, no anesthesia, no permanent bodily alteration, and no compensatory sweating. For most people, they represent the appropriate first course of action — and the evidence suggests they are effective for the majority of people who apply them properly.

For a structured, practical approach to those techniques, see the How to Stop Blushing guide.